What You Should Know:– Invitae (NYSE: NVTA), a medical genetics company, announced the completion of its sale of certain reproductive health assets, including carrier screening and non-invasive prenatal screening (NIPS), to Natera (NASDAQ: NTRA).– The transaction is valued at up to $52.5M, comprised of cash, milestone payments, and litigation credits.Streamlining Focus on Oncology and Rare […]
